Literature DB >> 1663287

Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines.

P Vannier1, E Hutet, E Bourgueil, R Cariolet.   

Abstract

Seven deleted Aujeszky's disease vaccines were compared for their ability to induce an immunity which suppresses virus excretion. For each vaccine, the levels of clinical protection and viral excretion were compared. Groups of eight pigs were vaccinated twice with attenuated deleted Aujeszky's disease vaccines (which do not express certain glycoproteins: gI, gX or gp63). Pigs were vaccinated at the beginning of the fattening period and challenge took place at the end of it when the pigs were 18-19 weeks old. Live virus vaccines were suspended in water or in an oil-in-water emulsion. The experiment was performed in three successive assays of two groups of eight pigs (except three groups for the first assay). At each assay, a control unvaccinated group of eight pigs was added to compare the effects of challenge between vaccinated and unvaccinated animals. In total, 80 pigs were involved in this experiment. All the vaccinated pigs excreted virus from 3 to 9 d after challenge. However the level of viral excretion and the duration of the period of excretion were reduced after vaccination and especially, when oil-in-water emulsion was used. There were obvious differences between vaccines. With some vaccines, when the level of viral excretion was low, the level of clinical protection was high. However, in other cases, the level of clinical protection could be good despite a higher level of viral excretion. The seroneutralizing titres were significantly and inversely related to a low level of viral excretion but not to the level of clinical protection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663287     DOI: 10.1016/0378-1135(91)90129-4

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Correlation between gI, gII, gIII, and gp 50 antibodies and virus excretion in vaccinated pigs infected with pseudorabies virus.

Authors:  M Eloit; P Vannier; E Hutet; A Fournier
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 2.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Limited protection conferred by a DNA vaccine against a lethal pseudorabies virus infection at day 5 postvaccination.

Authors:  Daniel Dory; Anne-Marie Torché; Véronique Béven; Roland Cariolet; André Jestin
Journal:  Clin Vaccine Immunol       Date:  2007-02-14

4.  Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  E Albina; L Piriou; E Hutet; R Cariolet; R L'Hospitalier
Journal:  Vet Immunol Immunopathol       Date:  1998-02-16       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.